The upregulation of the GluN2A subunit exerted no effects on the pharmacological properties of the NMDARs in our slice experiments [13], as it was proved that GluN2B was more likely to be responsible for the augmentation of Glu-induced excitatory activity in epilepsy [38]. Here, GRIN2B is linked to epilepsy.